• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • T. Arai, M. Hasegawa, +8 authors T. Oda
  • Biology, Medicine
  • Biochemical and biophysical research…
  • 2006 (First Publication: 1 December 2006)
  • Ubiquitin-positive tau-negative neuronal cytoplasmic inclusions and dystrophic neurites are common pathological features in frontotemporal lobar degeneration (FTLD) with or without symptoms of motorExpand
  • Norio Akuta, Fumitaka Suzuki, +13 authors Hiromitsu Kumada
  • Medicine, Biology
  • Hepatology
  • 2010 (First Publication: 1 August 2010)
  • UNLABELLED Genetic variation near the IL28B gene and substitution of amino acid (aa) 70 and 91 in the core region of hepatitis C virus (HCV) genotype 1b can predict the response to pegylatedExpand
  • N. Akuta, F. Suzuki, +9 authors H. Kumada
  • Medicine
  • Journal of hepatology
  • 2007 (First Publication: 1 March 2007)
  • BACKGROUND/AIMS We showed previously that amino acid (aa) substitutions in the HCV core region (HCV-CR) are predictors of non-virological response (NVR) to peginterferon (PEG-IFN) plus ribavirinExpand
  • Fumitaka Suzuki, Hitomi Sezaki, +13 authors Hiromitsu Kumada
  • Medicine, Biology
  • Journal of clinical virology : the official…
  • 2012 (First Publication: 1 August 2012)
  • BACKGROUND Hepatitis C virus (HCV) of genotype 1b is the most prevalent worldwide, and the least responsive to interferon-based treatments. A combination therapy with two direct-acting antivirals hasExpand
  • Kazuaki Chayama, Shoichi Takahashi, +7 authors Hiromitsu Kumada
  • Medicine
  • Hepatology
  • 2012 (First Publication: 1 March 2012)
  • UNLABELLED Patients with chronic hepatitis C virus (HCV) infection and previous null response to pegylated interferon (Peg-IFN) and ribavirin (RBV) have limited therapeutic options. HCV genotype 1 isExpand
  • S. Yamasaki, H. Hasegawa, +17 authors T. Tsuzuki
  • Medicine
  • Japanese journal of cancer research : Gann
  • 1996 (First Publication: 1 February 1996)
  • To clarify whether pre‐operalive transcatheter arterial embolization (TAE) improves survival after hepatectomy, a prospective randomized comparative study was done. Of a total of 115 registeredExpand